Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2011 Dec 13;10850:20184-8. doi: 10.1073/pnas.1117975108.
Show Gene links
Show Anatomy links
Physiological characterization of human muscle acetylcholine receptors from ALS patients.
Palma E, Inghilleri M, Conti L, Deflorio C, Frasca V, Manteca A, Pichiorri F, Roseti C, Torchia G, Limatola C, Grassi F, Miledi R.
???displayArticle.abstract???
Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of motor neurons leading to muscle paralysis. Research in transgenic mice suggests that the muscle actively contributes to the disease onset, but such studies are difficult to pursue in humans and in vitro models would represent a good starting point. In this work we show that tiny amounts of muscle from ALS or from control denervated muscle, obtained by needle biopsy, are amenable to functional characterization by two different technical approaches: "microtransplantation" of muscle membranes into Xenopus oocytes and culture of myogenic satellite cells. Acetylcholine (ACh)-evoked currents and unitary events were characterized in oocytes and multinucleated myotubes. We found that ALS acetylcholine receptors (AChRs) retain their native physiological characteristics, being activated by ACh and nicotine and blocked by α-bungarotoxin (α-BuTX), d-tubocurarine (dTC), and galantamine. The reversal potential of ACh-evoked currents and the unitary channel behavior were also typical of normal muscle AChRs. Interestingly, in oocytes injected with muscle membranes derived from ALS patients, the AChRs showed a significant decrease in ACh affinity, compared with denervated controls. Finally, riluzole, the only drug currently used against ALS, reduced, in a dose-dependent manner, the ACh-evoked currents, indicating that its action remains to be fully characterized. The two methods described here will be important tools for elucidating the role of muscle in ALS pathogenesis and for developing drugs to counter the effects of this disease.
Akk,
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
2005, Pubmed
Akk,
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
2005,
Pubmed Bellingham,
A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
2011,
Pubmed Bernareggi,
Microtransplantation of acetylcholine receptors from normal or denervated rat skeletal muscles to frog oocytes.
2011,
Pubmed
,
Xenbase Borroni,
Cholesterol depletion activates rapid internalization of submicron-sized acetylcholine receptor domains at the cell membrane.
2007,
Pubmed Butsch,
Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?
2007,
Pubmed Corona,
Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis.
2007,
Pubmed Cull-Candy,
Denervation changes in normal and myasthenia gravis human muscle fibres during organ culture.
1982,
Pubmed Dadon-Nachum,
The "dying-back" phenomenon of motor neurons in ALS.
2011,
Pubmed Dobrowolny,
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.
2005,
Pubmed Doppler,
Myogenesis in human denervated muscle biopsies.
2008,
Pubmed Dupuis,
Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
2009,
Pubmed Eusebi,
Liposome-delivered phosphatidylcholine enhances the acetylcholine sensitivity of dystrophic mouse myotubes.
1986,
Pubmed Eusebi,
Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information.
2009,
Pubmed
,
Xenbase Fischer,
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.
2004,
Pubmed Frey,
Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.
2000,
Pubmed Fucile,
The human adult subtype ACh receptor channel has high Ca2+ permeability and predisposes to endplate Ca2+ overloading.
2006,
Pubmed Grassi,
Cholinergic responses in cloned human TE671/RD tumour cells.
1993,
Pubmed Grassi,
Fusion-independent expression of functional ACh receptors in mouse mesoangioblast stem cells contacting muscle cells.
2004,
Pubmed Gullo,
Orchestration of "presto" and "largo" synchrony in up-down activity of cortical networks.
2010,
Pubmed KATZ,
FURTHER OBSERVATIONS ON THE DISTRIBUTION OF ACTYLCHOLINE-REACTIVE SITES IN SKELETAL MUSCLE.
1964,
Pubmed Krause,
Activation of nicotinic acetylcholine receptors increases the rate of fusion of cultured human myoblasts.
1995,
Pubmed Lamanauskas,
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
2008,
Pubmed Magistris,
Needle muscle biopsy in the investigation of neuromuscular disorders.
1998,
Pubmed Marsal,
Incorporation of acetylcholine receptors and Cl- channels in Xenopus oocytes injected with Torpedo electroplaque membranes.
1995,
Pubmed
,
Xenbase Miledi,
Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes.
2002,
Pubmed
,
Xenbase Miledi,
Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: new procedure for ion channel studies.
2006,
Pubmed
,
Xenbase MILEDI,
The acetylcholine sensitivity of frog muscle fibres after complete or partial devervation.
1960,
Pubmed MILEDI,
Junctional and extra-junctional acetylcholine receptors in skeletal muscle fibres.
1960,
Pubmed MILEDI,
Acetylcholine sensitivity of rat diaphragm maintained in organ culture.
1962,
Pubmed Mohammadi,
Interaction of high concentrations of riluzole with recombinant skeletal muscle sodium channels and adult-type nicotinic receptor channels.
2002,
Pubmed Moriconi,
Mechanism of verapamil action on wild-type and slow-channel mutant human muscle acetylcholine receptor.
2010,
Pubmed Musarò,
State of the art and the dark side of amyotrophic lateral sclerosis.
2010,
Pubmed Nagańska,
Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study.
2010,
Pubmed Nakamizo,
Stimulation of nicotinic acetylcholine receptors protects motor neurons.
2005,
Pubmed Nakanishi,
Regulation of motoneuron excitability via motor endplate acetylcholine receptor activation.
2005,
Pubmed Palma,
Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy.
2002,
Pubmed
,
Xenbase Pradat,
Abnormalities of satellite cells function in amyotrophic lateral sclerosis.
2011,
Pubmed Shao,
Potentiation and inhibition of nicotinic acetylcholine receptors by spermine in the TE671 human muscle cell line.
1998,
Pubmed Villarroel,
Calcium permeability increase of endplate channels in rat muscle during postnatal development.
1996,
Pubmed
,
Xenbase Witzemann,
Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses.
1991,
Pubmed Yvon,
Riluzole-induced oscillations in spinal networks.
2007,
Pubmed Zinman,
Emerging targets and treatments in amyotrophic lateral sclerosis.
2011,
Pubmed
